The lengthening list of pharma alliances focused on molecular glue degraders has another entry after Novartis signed a deal with Monte Rosa Therapeutics worth up to $2.2 billion. The partnership – ...

This profile has not been claimed by the company. See reviews below to learn more or submit your own review. Honeywell Heaters produces heating equipment for home and office environments. Its products ...

Cipherlab Co Ltd (6160) Cipherlab Co Ltd stock price live, this page displays TWO 6160 stock exchange data. View the 6160 premarket stock price ahead of the market session or assess the after hours ...

BOSTON, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today ...

Monte Rosa Therapeutics shares jumped this week after the company expanded its collaboration with Novartis. The Novartis partnership brings significant upfront cash and external QuEEN platform ...

Location: 6160 N. Scottsdale Road, just south of Rose Lane. Description: Western Addition, a Texas-based restaurant group, is working on its first out-of-state expansion by bringing an upscale Italian ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Honeywell bucked the trend in earnings season and raised the midpoint of its guidance. The company stands relatively well placed to deal with the tariff conflict. Honeywell is headed for a breakup, ...

Monte Rosa Therapeutics Inc. (NASDAQ:GLUE) on Thursday revealed clinical results from its MRT-6160 Phase 1 single ascending dose/multiple ascending dose (SAD/MAD) study. The study objectives were to ...

One of Monte Rosa Therapeutics' main differentiating factors is its proprietary QuEEN platform to design new molecular glue degraders. This process also leverages AI. They now have two important ...

With a data strategy fully in place, the multinational conglomerate now seeks to streamline end-to-end processes and reduce employee admin tasks with gen AI. Having spent years transforming into a ...